Neonatal Respiratory Distress Syndrome Flashcards

1
Q

Which neonates are more likely to get Respiratory Distress Syndrome (RDS)

A

Less than 36 weeks gestational age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathophysiology of RDS

A

Pulmonary surfactant deficiency: inadequate surfactant will require higher inspiratory pressures to re-expand alveoli and achieve gas exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the roles of pulmonary surfactant

A

Decreases surface tension forces at air:fluid interface at alveoli, prevents alveolar collapse (atelactasis), facilitates clearance of pulmonary fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why are neonates less than 36 weeks more likely to acquire RDS

A

Endogenous cortisol stimulates synthesis and secretion of pulmonary surfactant at 30-32 weeks of gestation and sufficient amounts are not reached until 36 weeks of gestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the increased risk risk factors

A

Prematurity, gestational diabetes, C-section without labor, male gender

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the decreased risk risk factors

A

Maternal hypertension, maternal narcotic addition, cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the sequence of events caused by diminished surfactant

A

Progressive atelectasis -> hypoventilation -> increased partial carbon dioxide/decreased oxygen/low pH -> hypotension -> pulmonary vasoconstriction -> alveolar hypoperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the clinical presentation of a patient with RDS, when would this be seen

A

Tachypnea, hypoxemia, hypercapnia, within the first six hours of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Who is RDS diagnosed

A

X-ray findings (diffuse reticulogranular pattern)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the medication used to treat RDS, how does it alleviate the problem

A

Antenatal glucocorticoids: increases production fibroblast neumocyte factor, stimulates biosynthesis of surfactant in type II pneumocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the atenatal glucoroticoids given

A

Betamethasone 12 mg IM every 24 hours for 2 doses OR dexamethasone 6mg IM every 12 hours for 4 doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the categories of drugs that are given to prevent premature delivery and allow for the steroids to start working

A

Beta-adnergic agonists, magnesium sulfate, prostaglandin inhibitors, calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the beta-adnergic agonist used to prevent premature delivery

A

Terbutaline (No longer used due to adverse effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MOA of magnesium for preventing premature delivery, what concentration does the magnesium sulfate need to be at

A

Inhibiting voltage- independent calcium channels at myometrial cell surface, 4-8 mg/dL (loading dose IV then continuous infusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the adverse effects of magnesium sulfate in the mother, in the neonate

A

Mother: N/V, flushing, headache, blurred vision, pulmonary edema, shortness of breath, chest pains

Neonate: respiratory depression, slow GI function (also has neonatal neuroprotection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is used in conjunction with magnesium to prevent preterm delivery, when can it ONLY BE TAKEN

A

Indomethacin, gestation age LESS THAN 30 weeks

17
Q

What is the only CCB that can be used to prevent premature delivery. adeverse effects

A

Nifedipine, headache, tachycardia, palpatations

18
Q

If a patient has RDS what can be done for supportive care to aid in breathing, what is this to prevent

A

Supplemental O2, CPAP, mechanical ventillation/ respiratory and metabolic acidosis

19
Q

What is a common problem for patients with RDS, how can this be prevented

A

Pulmonary Edema, 120-130 ml/kg/day

20
Q

When would diuretic be used in a patient with RDS, which diuretic would be used, what is the largest con with doing this

A

Reserved for neonates with pulmonary edema OR cannot be removed from the ventilator, furosemide 1-2 mg/kg/day in 1-2 divided doses, increases the ductus arterious opening

21
Q

What is adequate nutrion for patients with RDS, empiric antibiotic therapy to prevent what

A

100-110 kcal/kg/day/ ampicillin and gentamicin to prevent sepsis

22
Q

What is the major surface-active component of human surfactant, most important proteins for human surfactant for patients with RDS and why

A

DPPC or lecithin/ SP-B and SP-C: enhances spreadability and surface adsorption leading to DECREASED SURFACE TENSION

23
Q

What are the three FDA approved surfactant products for treatment and prevention of RDS

A

Beractant: 100 mg/kg PL , calfactant: 105 mg/kg PL, poractant: 200 mg/kg PL

24
Q

What are the natural surfactants, ones used for prevention and treatment, treatment only

A

Calfactant and Poractant, calfactant and Beractant/ Poractant

25
T/F: Patients must be intubated in order to recieve natural surfactants
True
26
What are the therapeutic effects of natural surfactants
Decreased supplemental oxygen and mechanical ventilation, decreased incidence of pneumothorax and PIE, increase survival by 40% regardless of birth weight or gestation age, reduce mortality of RDS by 50%
27
What is the benefits of using the natural surfactants (calfactant and poractant), what is a significant improvement of poractant
Longer duration of effect (dosed every 12 hours), faster weaning from the ventilator, less supplemental oxygen required/ lower incidence or mortality and re-dosing
28
When is it best to use surfactants in patients with RDS
Early therapy: given within two hours of life, Rescue therapy: once the patient is diagnosed
29
How is it known a patient needs a 2nd dose of surfactant
Intubated infant requiring FIO2 greater than or equal to 30% to maintain arterial PaO2 greater than or equal to 50 mmHg or oxygen saturation greater than 90%
30
What are the monitoring parameters of giving surfactants
heart rate, oxygen saturation, arterial blood gas
31
What are the adverse effects of giving surfactants
oxygen desaturation, transient bradycardia, mucous plugging, increased risk of pulmonary hemmorrhage and apnea